Ori Gutwerg - 26 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role: SVP, GENERICS
Signature: /s/ Ori Gutwerg, by attorney-in-fact Meredith W. Cook
Issuer symbol: ANIP
Transactions as of: 26 Feb 2026
Net transactions value: +$836,426
Form type: 4
Filing time: 02 Mar 2026, 17:58:40 UTC
Previous filing: 17 Feb 2026
Next filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gutwerg Ori	SVP, GENERICS	C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE	/s/ Ori Gutwerg, by attorney-in-fact Meredith W. Cook	02 Mar 2026	0001846478

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIP	Common Stock	Award	$1,000,558	+12,969	+17%	$77.15	89,063	26 Feb 2026	Direct	F1
transaction	ANIP	Common Stock	Tax liability	$164,132	-2,221	-2.5%	$73.90	86,842	28 Feb 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.
F2	Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.